Van Den Berg Management I’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.6M Sell
27,514
-600
-2% -$223K 2.25% 15
2026
Q1
$8.23M Buy
28,114
+1,115
+4% +$366K 1.89% 19
2025
Q4
$9.46M Sell
26,999
-1,475
-5% -$498K 2.17% 15
2025
Q3
$9.2M Buy
28,474
+10,004
+54% +$3.11M 2.31% 15
2025
Q2
$7.18M Buy
18,470
+1,261
+7% +$507K 2.04% 19
2025
Q1
$7.49M Buy
17,209
+611
+4% +$245K 2.29% 17
2024
Q4
$6.12M Buy
16,598
+4,994
+43% +$2.09M 1.76% 21
2024
Q3
$6.03M Sell
11,604
-144
-1% -$76.9K 1.75% 21
2024
Q2
$6.37M Sell
11,748
-7
-0.1% -$3.7K 1.89% 20
2024
Q1
$6.1M Buy
11,755
+925
+9% +$460K 1.79% 20
2023
Q4
$5.11M Buy
10,830
+453
+4% +$209K 1.7% 22
2023
Q3
$4.52M Buy
+10,377
New +$4.71M 1.58% 26

Other funds holding ELV

Van Den Berg Management I's ELV Position: Q2 2026 in Review

Van Den Berg Management I reduced its Elevance Health (ELV) stake by 2.1% in Q2 2026, selling an estimated $223K and leaving 27,514 shares worth $10.6M. The position accounts for 2.25% of the portfolio, ranked #15.

Van Den Berg Management I first reported a position in ELV in Q3 2023 and has held it in 12 quarters since. 1,609 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Van Den Berg Management I held 27,514 shares of Elevance Health worth $10.6M as of Q2 2026.
  • Van Den Berg Management I sold 600 Elevance Health shares in Q2 2026, an estimated $223K.
  • Elevance Health made up 2.25% of Van Den Berg Management I's portfolio in Q2 2026, its #15 holding.
  • Van Den Berg Management I first reported a position in Elevance Health in Q3 2023 and has held it in 12 quarters since.
  • 1,609 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Van Den Berg Management I's 13F filing for Q2 2026, filed 14 Aug 2026.